Mallinckrodt Plc (MNKKQ) Return on Assets ROA from the second quarter of 2026 to second quarter of 2022 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Apr 01 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mallinckrodt Plc  (MNKKQ)


Mallinckrodt Plc's ROA from the second quarter of 2026 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Mallinckrodt Plc's ROA in the second quarter of 2026?
Mallinckrodt Plc achieved a return on average assets (ROA) of 3.24 % in its second quarter of 2026, this is above MNKKQ's average return on assets of -4.49%.
Mallinckrodt Plcs assets during the 12 months ending in the second quarter of 2026 are valued at $6 billion

ROA decreased relative to the period ending Jun 27 2025, due to the decline in net income.

However, within the Healthcare sector 347 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3913, from total ROA ranking in the second quarter of 2025 at 4163.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Jun 27 2025)
II. Quarter		 (Dec 27 2024)
IV. Quarter		 (Jun 16 2022)
II. Quarter		 (Apr 01 2022)
I. Quarter
Y / Y Total Assets Change -40.27 % -65.5 % -18.41 % -7.75 % -8.23 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 201 302 96 -781 -693
Return On Assets (TTM) 3.24 % 4.26 % 1.11 % -8.65 % -7.52 %
MNKKQ's Total Ranking # 3913 # 4163 # 3411 # 3098 # 3472
Total Assets (TTM) in million 5,325 3,159 7,618 8,705 8,916
Seq. Total Assets Change 68.56 % -58.53 % -12.49 % -2.37 % -2.64 %
Seq. Net Income Change - -99.61 % - - -

MNKKQ's 5 Years Annual ROA >> Back to MNKKQ Management Effectiveness >> Compare MNKKQ ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 118
Sector # 348
Overall # 3862

Return On Assets Statistics
High Average Low
14.4 %
-4.49 %
-33.88 %
(Dec 29 2017)   (Sep 27 2019)





Financial Statements
Mallinckrodt Plc's Assets $ 5,325 million MNKKQ's Balance sheet
Mallinckrodt Plc's Income $ -221 million Quarterly MNKKQ's Income Statement
MNKKQ's Income by Division See MNKKQ's Income by Division



Annual Return On Assets (Dec 27 2024)
FY 2024		 (Dec 31 2021)
FY 2021		 (Dec 25 2020)
FY 2020		 (Dec 27 2019)
FY 2019		 (Dec 28 2018)
FY 2018
Y / Y Total Assets Change 27.56 % -8.23 % -6.03 % -4.95 % -28.82 %
Total Assets in million 11,374 8,916 9,715 10,339 10,877
Y / Y Net Income Change - - - - -
Net Income in million 478 -717 -945 -997 -3,607
Annual Return On Assets 4.2 % -8.05 % -9.72 % -9.64 % -33.16 %

MNKKQ's 5 Years Annual ROA >> Back to MNKKQ Management Effectiveness >> Compare MNKKQ ROA to its Competitors



Comment on MNKKQ's ROA in the fiscal year ending 2024
In the fiscal year 2024 ROA improved to 4.2 % compared to prior year, due to annual net income growth of % to $477.90 million, while value of Mallinckrodt Plc's overall assets grew just by 27.56 % to $11,373.80 million, compared to $11,373.80 a year before.


More Return On Assets Ratios
MNKKQ's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MNKKQ's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MNKKQ's Competitors
Subscribers only: Roa for Mallinckrodt Plc's Suppliers
Subscribers only: Return On Assets for MNKKQ's Customers

You may also want to know
MNKKQ's Roi MNKKQ's Inventory Turnover Ratio MNKKQ's Growth Rates MNKKQ's Dividend Comparisons
MNKKQ's Profitability Ratios MNKKQ's Asset Turnover Ratio MNKKQ's Dividend Growth
MNKKQ's Roe MNKKQ's Valuation Ratios MNKKQ's Financial Strength Ratios MNKKQ's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Infusystem Holdings Inc  8.63 %
Penumbra Inc  8.63 %
Utah Medical Products Inc  8.50 %
Boston Scientific Corporation  8.34 %
3m Company  8.27 %
Jazz Pharmaceuticals Plc  8.19 %
Pediatrix Medical Group Inc   8.09 %
Veracyte Inc   8.04 %
Stryker Corp  7.89 %
Lifevantage Corp  7.87 %
Embecta Corp   7.82 %
Beone Medicines Ltd   7.82 %
Viemed Healthcare Inc   7.49 %
Edwards Lifesciences Corporation  7.41 %
Ani Pharmaceuticals Inc  7.40 %
Addus Homecare Corp  7.32 %
Livanova Plc  7.31 %
Pacific Health Care Organization Inc  7.17 %
Nature s Sunshine Products inc   7.14 %
Bio techne Corp  7.12 %
Concentra Group Holdings Parent Inc   7.09 %
Phibro Animal Health Corporation  7.01 %
Ensign Group Inc  6.88 %
Royalty Pharma Plc  6.87 %
Davita Inc   6.77 %
Quest Diagnostics Inc  6.74 %
Align Technology inc   6.56 %
Corcept Therapeutics Inc  6.45 %
Brightspring Health Services Inc   5.93 %
Amneal Pharmaceuticals Inc   5.90 %

Date modified: 2026-09-26T06:54:28+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.